SCHEMBL21322325

SCHEMBL21322325

CC(c1cccc(-c2ncc(OCC3CCN(C(=O)OC(C)(C)C)CC3)cn2)c1)n1cc(Br)ccc1=O

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 3/20 0.47
▸ GPR119 Q8TDV5 6/20 0.44
▸ SLC2A1 P11166 1/20 0.41
▸ CHEK2 O96017 1/20 0.41
▸ HDAC1 Q13547 1/20 0.40
▸ HPGDS O60760 2/20 0.39
▸ NQO2 P16083 1/20 0.38
▸ ALOX5AP P20292 1/20 0.38
▸ FEN1 P39748 1/20 0.38
▸ FNTA P49354 1/20 0.38
▸ FNTB P49356 1/20 0.38
▸ NOTCH1 P46531 1/20 0.37
▸ PDE4D Q08499 1/20 0.37
▸ IRAK1 P51617 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21322099 0.89 MET (0.57) METGPR119SLC2A1CHEK2HDAC1
SCHEMBL21264622 0.86 MET (0.45) METGPR119SLC2A1CHEK2HDAC1
SCHEMBL21322326 0.86 MET (0.45) METGPR119SLC2A1CHEK2HDAC1
SCHEMBL23714116 0.84 MET (0.54) METGPR119SLC2A1CHEK2HDAC1
SCHEMBL21264726 0.84 GPR119 (0.51) METGPR119SLC2A1CHEK2HDAC1
SCHEMBL21322331 0.83 MET (0.50) METGPR119NQO2
SCHEMBL21322264 0.83 MET (0.47) METGPR119SLC2A1CHEK2HDAC1
SCHEMBL22310752 0.83 GPR119 (0.51) METGPR119SLC2A1CHEK2HDAC1
SCHEMBL21264882 0.83 MET (0.57) METGPR119SLC2A1CHEK2HDAC1
SCHEMBL21322333 0.83 MET (0.57) METGPR119SLC2A1CHEK2HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3533787-B1 PYRIDONE COMPOUND AS C-MET INHIBITOR FUJIAN COSUNTER PHARMACEUTICAL CO LTD (CN) 2020-09-30 — — EP disclosed
EP-3533787-A1 PYRIDONE COMPOUND AS C-MET INHIBITOR Fujian Cosunter Pharmaceutical Co., Ltd. (CN) 2019-09-04 — — EP disclosed
Send feedback